| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |